Free World Trust v. Électro Santé Inc., [2000] 2 S.C.R. 1024
Free World Trust Appellant
v.
Électro Santé Inc., Paul Demers and Noël Desjardins Respondents
and
Promotion R.A.S. (1992) Inc.
and Électronique SEM Inc. Plaintiffs
before
the Superior Court
and
Procter & Gamble Inc. Intervener
Indexed as: Free World Trust v. Électro Santé Inc.
Neutral citation: 2000 SCC 66.
File No.: 26406.
1999: December 14; 2000: December 15.
Present: L’Heureux‑Dubé, Gonthier, McLachlin, Iacobucci,
Major, Bastarache and Binnie JJ.
on appeal from the court of appeal for quebec
Patents – Infringement – Validity – Scope and ambit
of patent owner’s monopoly – Anticipation by publication – Extent to which
patent monopoly protects “substance” of invention – Whether claims patented
sufficiently elastic to catch competitor’s machine.
The appellant is the owner of two patents of invention
issued in 1981 and 1983 which relate to an apparatus that bombards different
parts of the human body with low frequency electro-magnetic waves. The system
discovered by the appellant was for a new method of controlling the amplitude
and frequency of the electro‑magnetic waves by “circuit means”. The
respondent company developed and marketed an apparatus which achieved similar
therapeutic purposes, but employed somewhat different technology, using instead
a “microcontroller”. The appellant acknowledged the difference, but argued
that the end result was the same and therefore its patent monopoly was
infringed. The trial judge ruled the patents anticipated and thus invalid.
The Court of Appeal reversed the finding of invalidity but found there was no
infringement.
Held: The appeal
should be dismissed.
The interpretive task of the court in claims
construction is to separate and distinguish the essential from the inessential
and to give to the “field” of the monopoly framed by the essential elements of
the claims the legal protection to which the holder of a valid patent is
entitled. The essential elements common to the claims of both patents in suit
include a control to regulate the peak amplitude and frequency of electro‑magnetic
waves by “circuit means”. The claimed invention effected an ingenious
combination rather than a mere aggregation of previously known components. The
invention was not anticipated by a prior publication that did not address the
technical problems dealt with in these patents.
The more difficult issue is how best to resolve the
tension between “literal infringement” and “substantive infringement”. The Patent
Act seeks both fairness and predictability. Its objective of promoting
research and development would be undermined if competitors fear to tread in
the vicinity of the patent because its scope lacks a reasonable measure of
precision and certainty. Predictability is achieved by tying the patentee to
its claims and fairness is achieved by interpreting those claims in an informed
and purposive way.
The greater the level of discretion left to courts to
peer below the language of the claims in a search for the “spirit of the
invention”, the less the claims can perform their public notice function, and
the greater the resulting level of unwelcome uncertainty and unpredictability.
“Purposive construction” does away with a purely literal interpretation but
disciplines the scope of the “substantive” claims construction in the interest
of fairness to both the patentee and the public. Some elements of a claimed
invention are essential while others are non‑essential. These are
identified, on the basis of the common knowledge of the worker skilled in the
art to which the patent relates as of the date the patent is published (under
the current provisions of the Patent Act the date of publication is the
“laid open” date). There is no infringement if an essential element is
different or omitted in the allegedly infringing device, but there may still be
infringement if non‑essential elements are substituted or omitted. For
an element to be considered non‑essential and thus substitutable, it must
be shown either that on a purposive construction of the words of the claim it
was clearly not intended to be essential, or that at the date of publication of
the patent, the skilled addressee would have appreciated that a particular
element could be substituted or omitted without affecting the working of the
invention.
Based on the foregoing principles, the respondents'
device does not infringe. The ingenuity of these patents lay not in their
identification of a desirable result but in teaching particular means to
achieve it. The claims cannot be stretched to allow the patentee to monopolize
anything that achieves the desirable result. The respondents' device differs both
structurally and operationally from the device contemplated in the claims. The
use of a “microcontroller” substituted a totally different technology and was
fatal to the appellant's allegation of infringement.
Cases Cited
Referred to: Clothworkers
of Ipswich Case (1653), Godb. 252, 78 E.R. 147; Minerals
Separation North American Corp. v. Noranda Mines, Ltd., [1947] Ex. C.R.
306; Consolboard Inc. v. MacMillan Bloedel (Sask.) Ltd., [1981] 1 S.C.R.
504; General Tire & Rubber Co. v. Firestone Tyre & Rubber Co.,
[1972] R.P.C. 457; Beloit Canada Ltd. v. Valmet OY (1986), 8 C.P.R. (3d)
289; The King v. Uhlemann Optical Co., [1952] 1 S.C.R. 143; Domtar
Ltd. v. MacMillan Bloedel Packaging Ltd. (1977), 33 C.P.R. (2d) 182; Grip
Printing and Publishing Co., of Toronto v. Butterfield (1885), 11 S.C.R.
291; Graver Tank & Mfg. Co. v. Linde Air Products Co., 339 U.S. 605
(1950); Electrolier Manufacturing Co. v. Dominion Manufacturers Ltd.,
[1934] S.C.R. 436; Smith Incubator Co. v. Seiling, [1936] S.C.R. 251; J.
K. Smit & Sons, Inc. v. McClintock, [1940] S.C.R. 279; Gillette
Safety Razor Co. of Canada v. Pal Blade Corp., [1933] S.C.R. 142; Warner-Jenkinson
Co. v. Hilton Davis Chemical Co., 520 U.S. 17 (1997); Clark v.
Adie (1873), L.R. 10 Ch. 667; Electric &
Musical Industries Ld. v. Lissen Ld. (1939), 56 R.P.C. 23;
Catnic Components Ltd. v. Hill & Smith Ltd., [1982] R.P.C. 183; Interpress
Associates Ltd. v. Pacific Coilcoaters Ltd. (1994), 29 I.P.R. 635; Smale
v. North Sails Ltd., [1991] 3 N.Z.L.R. 19; Populin v. H.B. Nominees Pty.
Ltd. (1982), 59 F.L.R. 37; Rhone-Poulenc Agrochimie SA v. UIM Chemical
Services Pty. Ltd. (1986), 68 A.L.R. 77; Multotec Manufacturing (Pty.)
Ltd. v. Screenex Wire Weaving Manufacturers (Pty.) Ltd., 1983 (1) SA 709; Sappi
Fine Papers (Pty.) Ltd. v. ICI Canada Inc. (Formerly CIL Inc.), 1992 (3) SA
306; Improver Corp. v. Raymond Industrial Ltd., [1991] F.S.R.
233; Eli Lilly & Co.v. O'Hara Manufacturing Ltd. (1989), 26 C.P.R.
(3d) 1; R. v. Nova Scotia Pharmaceutical Society, [1992] 2 S.C.R. 606; R.C.A.
Photophone, Ld. v. Gaumont-British Picture Corp. (1936), 53 R.P.C. 167; Western
Electric Co. v. Baldwin International Radio of Canada, [1934] S.C.R. 570; Mobil
Oil Corp. v. Hercules Canada Inc. (1995), 63 C.P.R. (3d) 473; Computalog
Ltd. v. Comtech Logging Ltd. (1992), 44 C.P.R. (3d) 77; Feherguard
Products Ltd. v. Rocky's of B.C. Leisure Ltd. (1995), 60 C.P.R. (3d) 512; Cutter
(Canada) Ltd. v. Baxter Travenol Laboratories of Canada Ltd. (1983),
68 C.P.R. (2d) 179; Johnson Controls, Inc. v. Varta Batteries Ltd.
(1984), 80 C.P.R. (2d) 1; Whirlpool Corp. v. Camco Inc., [2000] 2 S.C.R.
1067, 2000 SCC 67; Whirlpool Corp. v. Maytag Corp., [2000] 2 S.C.R.
1116, 2000 SCC 68; Improver Corp. v. Remington Consumer Products Ltd.,
[1990] F.S.R. 181; Biogen Inc. v. Medeva PLC, [1997] R.P.C. 1; Dyson
Appliances Ltd. v. Hoover Ltd., [2000] E.W.J. No. 4994 (QL); AT & T
Technologies, Inc. v. Mitel Corp. (1989), 26 C.P.R. (3d) 238; Lovell
Manufacturing Co. v. Beatty Bros. Ltd. (1962), 23 Fox Pat. C. 112; P.L.G.
Research Ltd. v. Jannock Steel Fabricating Co. (1991), 35 C.P.R. (3d) 346; Foseco
Trading A.G. v. Canadian Ferro Hot Metal Specialties, Ltd. (1991), 36
C.P.R. (3d) 35; Incandescent Gas Light Co. v. De Mare Incandescent Gas
Light System, Ld. (1896), 13 R.P.C. 301.
Statutes and Regulations Cited
Convention
on the Grant of European Patents (European Patent Convention), October 5, 1973.
Patent Act, R.S.C., 1985, c. P-4, ss. 10 [rep. & sub. c. 33 (3rd Supp.),
s. 2 ; rep. & sub. 1993, c. 15, s. 28], 27(1), 28(2), 34, 44, 55(2) [rep.
& sub. c. 33 (3rd Supp.), s. 21 ; rep. & sub. 1993, c. 15, s. 48].
Statute of
Monopolies (1623).
Authors Cited
Annand, Ruth E. “Infringement
of Patents — Is “Catnic” the Correct Approach for Determining the Scope of a
Patent Monopoly Under the Patents Act 1977?” (1992), 21 Anglo-Am. L. Rev. 39.
Boudreau, Jean-Claude. “AT&T
Technologies: A Contribution to the Purposive Construction Approach for Patent
Infringement Analysis in Canada” (1998-99), 15 C.I.P.R. 323.
Fox, Harold G. The Canadian
Law and Practice Relating to Letters Patent for Inventions, 4th ed.
Toronto: Carswell, 1969.
Goldsmith, Immanuel. Patents of Invention. Agincourt, Ont.:
Carswell, 1981.
Hitchman, Carol V. E., and Donald
H. MacOdrum. “Don't Fence Me In: Infringement in Substance in Patent Actions”
(1990-91), 7 C.I.P.R. 167.
Sajewycz, Mark. “Patent Claim
Interpretation as It Should Be: Promoting the Objects of the Patent Act ”
(1996-97), 13 C.I.P.R. 173.
Scott, David W. “The Record of
Proceedings in the Patent Office in Canada & Foreign Countries as Evidence
in Infringement & Validity Contests” (1985-86), 2 C.I.P.R. 160.
Solov'eva, G. R. “Instrumentation
and Applications of Low-Frequency Magnetotherapy” (1975), 8 Biomedical
Engineering 166.
Sotiriadis, Bob H. “Purposive
Construction in Canadian Patent Infringement Cases Since O'Hara” (1996),
11 I.P.J. 111.
Takenaka, Toshiko. “Doctrine of Equivalents after Hilton Davis: A
Comparative Law Analysis” (1996), 22 Rutgers Computer & Tech. L.J.
479.
Terrell on the Law of Patents, 15th ed. By S. Thorley, R. Miller, G. Burkill and C. Birss.
London: Sweet & Maxwell, 2000.
Turner, Jonathan D. C. “Purposive
Construction: Seven Reasons Why Catnic is Wrong” (1999), 21 E.I.P.R.
531.
APPEAL from a judgment of the Quebec Court of
Appeal[1997] R.J.Q. 2907, 81 C.P.R. (3d) 456, [1997] Q.J. No. 3479 (QL),
allowing in part the appellant’s appeal from a judgment of the Superior Court,
holding that the appellant’s patents were invalid and that they had not been
infringed by the respondents. Appeal dismissed.
Louis Masson and Nathalie
Vaillant, for the appellant.
No one appeared for the respondents.
Bruce W. Stratton and Dino
P. Clarizio, for the intervener.
The judgment of the Court was delivered by
1
Binnie J. – The principal question that arises on this appeal is the extent to
which a patent monopoly protects “the substance” or “the spirit” of an
invention, as distinguished from what is literally described in the written
claims, and whether on the facts of this case the claims patented by the
appellant are sufficiently elastic to catch the electro-magnetotherapy
machine of the respondent Électro Santé Inc.
2
More specifically, the appellant concedes that the respondents' machine,
which is used in the treatment of such bodily ills as rheumatism and arthritis,
is not precisely as described in the written claims of its patents. It says,
however, that the respondents have stolen the substance of its invention and
claims an injunction plus compensatory and punitive damages.
3
The appeal thus raises important questions about the scope and ambit of
a patent owner's monopoly. Too much elasticity in the interpretation of the
scope of the claims creates uncertainty and stifles competition. Too little
protection robs inventors of the benefit they were promised in exchange for
making a full and complete disclosure of the fruits of their ingenuity. The Quebec Court of Appeal held that the respondents' machines took
neither the letter nor the substance of the appellant’s patents. I think this
conclusion was correct, although I get there by a somewhat different route.
The appeal must therefore be dismissed.
I. Facts
4
The appellant, Free World Trust, is the owner of two patents of
invention numbered 1,113,156 (the “'156 patent”) and 1,150,361 (the “'361
patent”) issued in 1981 and 1983 respectively. The patents relate to an
apparatus that bombards different parts of the human body with low frequency
electro-magnetic waves. Electro-magnetotherapy is not new, but the appellant
persuaded the Commissioner of Patents that it had discovered a new method of
controlling the amplitude and frequency of the electromagnetic waves by
“circuit means” with desirable and beneficial effects. The
appellants put the invention described in these patents on the market in the
form of an apparatus called Rhumart, which was a commercial success. In 1991,
the appellant sold 3,525 Rhumart systems for a total of $13,683,240.
5
On March 4, 1992, the respondent Paul Demers, one of the appellant’s
sales representatives, quit his employ with the appellant and started the
respondent company for the purpose of developing and marketing electro-magnetotherapy
machines in competition with his former firm. Within approximately six months
of Demers' departure from the appellant company, the “new” product was on
sale. The respondent Noël Desjardins, formerly an independent distributor for
the Rhumart system, joined Demers to provide distribution and marketing
expertise.
6
The respondents' apparatus (which it called “Électro-Santé”) achieved
similar therapeutic purposes, but employed somewhat different technology. The
present controversy revolves around these differences, and whether they are
sufficiently substantial to put the respondents outside the appellant's
monopoly. Of particular importance is the fact that the appellant's patents
teach the use of “control circuits” to regulate the magnetic field of waves or
pulses whose frequency, orientation and amplitude are critical to therapy. Its
Rhumart apparatus employed such “control circuits”. The respondents'
Électro-Santé machines, on the other hand, used a “microcontroller” which,
according to the appellant's own expert, is a [translation] “highly versatile element, similar to an IBM PC
computer or the like”. He acknowledged that this method of regulating the
magnetic field is different from what is contemplated in the claims of the
patent. The appellant's position, however, is that the end result was the same
and that its monopoly was thereby infringed.
II. Judgments
1. Trial Judgment (Quebec Superior Court -- Bergeron J.)
7
The trial judge ruled against the validity of the patents obtained by
the appellant. The Patent Act, R.S.C., 1985, c. P-4 , provides that a
patent cannot be granted for an invention in a publication printed in Canada or
in any other country more than two years prior to the patent application (ss.
27(1) and 28(2) ). In Bergeron J.'s view, the invention described in the
patent claims was anticipated by a 1975 article authored by
G. R. Solov'eva, entitled “Instrumentation and Applications of
Low-Frequency Magnetotherapy”. The Solov'eva article, he concluded, conveys
all of the fundamental elements needed to produce the claimed invention,
thereby rendering the patents anticipated and thus invalid:
[translation]
In my view, the Solov'eva article discloses all of the fundamental elements
necessary to allow a person skilled in the art or science of the relevant field
to make or construct the invention. We find present in this article all the
essential characteristics described in the patent claims. This is a
publication that describes the invention that is the subject of patents
1,113,156 and 1,150,316.
In light of
this conclusion, Bergeron J. dismissed the action without expressing an opinion
on the issue of patent infringement. The allegation of unfair competition on
the part of the respondents Demers and Desjardins was also rejected.
2. Court of Appeal (Rousseau-Houle J.A. for the Court) (1997),
81 C.P.R. (3d) 456
8
Rousseau-Houle J.A. cited the provision of the Patent Act which
creates a presumption in favour of the validity of a patent. The burden of
proving the invalidity of the appellant's patents on a balance of probabilities
rested on the respondents. The respondents failed to discharge this onus. The
Solov'eva article did not contain all of the essential elements of the patent
claims and a reading of it would not provide a person skilled in the art the
information necessary to build, without risk of error, the patented device.
Rousseau-Houle J.A. also rejected the arguments of lack of ingenuity and
inventiveness. Accordingly, the trial finding of invalidity was reversed and
patents '156 and '361 were declared valid.
9
On the issue of infringement, Rousseau-Houle J.A. considered the
principles applicable to claims construction and noted that the appellant's
case rested on an allegation of “substantive” infringement.
Rousseau-Houle J.A. identified certain differences and similarities between
the Électro-Santé and Rhumart systems and concluded that there were sufficient
differences to distinguish the Électro-Santé device and therefore rejected the
allegation of infringement. The appeal with respect to an injunction and
damages was therefore dismissed.
10
The respondents' trustee in bankruptcy elected not to participate in the
appeal to this Court. However, Procter & Gamble Inc. successfully applied
to intervene in support of the correctness of the outcome arrived at by the
Quebec Court of Appeal.
III. Relevant
Statutory Provisions
11
As the patents in suit were issued prior to October 1, 1989, the
provisions of the former Patent Act apply. The relevant sections of the
Patent Act, R.S.C., 1985, c. P-4 , provide as follows:
Section 27(1). [Application for
Patents]
Subject to this section, any inventor or legal
representative of an inventor of an invention that was
(a) not known or used by any other person before he invented
it,
(b) not described in any patent or in any publication printed
in Canada or in any other country more than two years before presentation of
the petition hereunder mentioned, and
(c) not in public use or sale in Canada for more than two years
prior to his application in Canada,
may, on presentation to the Commissioner of a petition setting out the
facts, in this Act termed the filing of the application, and on compliance with
all other requirements of this Act, obtain a patent granting to him an
exclusive property in the invention.
Section 28(2). [Limitation of
Two Years]
No patent shall be granted on an application for a
patent for an invention that had been patented or described in a patent or
publication printed in Canada or any other country more than two years before
the date of the actual filing of the application in Canada, or had been in
public use or on sale in Canada for more than two years prior to that filing.
Section 34. [Specification]
(1) An applicant shall in the specification
of his invention
(a) correctly and fully describe the invention and its
operation or use as contemplated by the inventor;
(b) set out clearly the various steps in a process, or the
method of constructing, making, compounding or using a machine, manufacture or
composition of matter, in such full, clear, concise and exact terms as to
enable any person skilled in the art or science to which it appertains, or with
which it is most closely connected, to make, construct, compound or use it;
(c) in the case of a machine, explain the principle thereof and
the best mode in which he has contemplated the application of that principle;
(d) in the case of a process, explain the necessary sequence,
if any, of the various steps, so as to distinguish the invention from other
inventions; and
(e) particularly indicate and distinctly claim the part,
improvement or combination that he claims as his invention.
(2) Claims to be stated distinctly–The
specification referred to in subsection (1) shall end with a claim or claims
stating distinctly and in explicit terms the things or combinations that the
applicant regards as new and in which he claims an exclusive property or
privilege.
Section
44. [What Patent Shall Contain and Confer]
Every patent granted under this Act shall contain
the title or name of the invention, with a reference to the specification, and
shall, subject to the conditions prescribed in this Act, grant to the patentee
and his legal representatives for the term therein mentioned, from the granting
of the patent, the exclusive right, privilege and liberty of making,
constructing, using and vending to others to be used the invention, subject to
adjudication in respect thereof before any court of competent jurisdiction.
12
The relevant amended provisions of the Patent Act, R.S.C., 1985,
c. P-4 , as amended by S.C. 1993, c. 15, provide as follows:
Section
10 . [Inspection by the Public]
(1) Subject to subsections (2) to (6) and section
20, all patents, applications for patents and documents filed in connection
with patents or applications for patents shall be open to public inspection at
the Patent Office, under such conditions as may be prescribed.
(2) Confidentiality period – Except with
the approval of the applicant, an application for a patent, or a document filed
in connection with the application, shall not be open to public inspection
before a confidentiality period of eighteen months has expired.
(3) Beginning of confidentiality period–The
confidentiality period begins on the filing date of the application or, where a
request for priority has been made in respect of the application, it begins on
the earliest filing date of any previously regularly filed application on which
the request is based.
Section 55. [Liability for
Patent Infringement]
(1) A person who infringes a patent is liable to
the patentee and to all persons claiming under the patentee for all damage
sustained by the patentee or by any such person, after the grant of the patent,
by reason of the infringement.
(2) Liability damage before patent is granted–A
person is liable to pay reasonable compensation to a patentee and to all
persons claiming under the patentee for any damage sustained by the patentee or
by any of those persons by reason of any act on the part of that person, after
the application for the patent became open to public inspection under section
10 and before the grant of the patent, that would have constituted an
infringement of the patent if the patent had been granted on the day the
application became open to public inspection under that section.
IV. Analysis
13
Patent protection rests on the concept of a bargain between the
inventor and the public. In return for disclosure of the invention to the
public, the inventor acquires for a limited time the exclusive right to exploit
it. It was ever thus. Even before the Statute of Monopolies (1623),
the Crown rewarded an inventor with a limited monopoly in exchange for public
disclosure of “a new invention and a new trade within the kingdom ... or if a
man hath made a new discovery of any thing”: Clothworkers of Ipswich Case
(1653), Godb. 252, 78 E.R. 147, at p. 148, where the court went on to say that
the effect of an unjustified monopoly was “to take away free-trade, which is
the birthright of every subject”. The argument for the
respondents is that the appellant has failed to live up to its side of the
bargain in two ways. In the first place, it did not make a new discovery of
anything. The appellant's patents teach nothing that was not well known
beforehand. Its patents are therefore invalid. Secondly, even if the patents
are valid, the appellant overreaches its bargain with the public by now
asserting a monopoly over devices that are in no way disclosed, taught or
claimed in its patents. The appellant is trying to get something for nothing.
The appellant has given no consideration for the patent protection it now
seeks. That is the argument.
1. The Claims in Suit
14
Patent claims are frequently analogized to “fences” and “boundaries”,
giving the “fields” of the monopoly a comfortable pretence of bright line
demarcation. Thus, in Minerals Separation North American Corp. v. Noranda
Mines, Ltd., [1947] Ex. C.R. 306, Thorson P. put the matter as follows, at
p. 352:
By his claims the inventor puts fences around the fields of his
monopoly and warns the public against trespassing on his property. His fences
must be clearly placed in order to give the necessary warning and he must not
fence in any property that is not his own. The terms of a claim must be free
from avoidable ambiguity or obscurity and must not be flexible; they must be
clear and precise so that the public will be able to know not only where it
must not trespass but also where it may safely go.
15
In reality, the “fences” often consist of complex layers of definitions
of different elements (or “components” or “features” or “integers”) of
differing complexity, substitutability and ingenuity. A matrix of descriptive
words and phrases defines the monopoly, warns the public and ensnares the
infringer. In some instances, the precise elements of the “fence” may be
crucial or “essential” to the working of the invention as claimed; in others
the inventor may contemplate, and the reader skilled in the art appreciate,
that variants could easily be used or substituted without making any material
difference to the working of the invention. The interpretative task of the
court in claims construction is to separate the one from the other, to
distinguish the essential from the inessential, and to give to the “field”
framed by the former the legal protection to which the holder of a valid patent
is entitled.
16
The issue in this case turns on the construction of claim 1 in each of
the two patents (as the other claims incorporate and build on claim 1, they
need not be considered at length).
(a) The '156 Patent
17
1. An electro-magnetic low frequency therapeutic system comprising a
magnetization coil, said magnetization coil being stationary during a magnetic
field treatment, for creating a preselected therapeutic magnetic field in
response to preselected coil energizing-current waveforms whereby said magnetic
field has desired treatment characteristics, said magnetic field having an
adjustable intensity set by adjustable control means, said control means also
having:
(i) circuit means for controlling the peak amplitude
of the said magnetic field for achieving a specific modulation of said peak
amplitude in a given time;
(ii) means to select the orientation and/or
direction of the therapeutic magnetic field with respect to a tissue to be
treated;
(iii) circuit means to select the frequency of
interruption of the coil energizing-current to obtain a selected one of
different therapeutic magnetic field time patterns;
(iv) means to select a desired treatment time;
automatic demagnetizing means responsive to a preselected demagnetizing time
and mode for attenuating said field in a desired manner to terminate a magnetic
field treatment.
(b) The '361 Patent
18
Claim 1 of the '361 patent offers certain improvements to the '156
patent; the major innovations lie in a more detailed treatment of the control
means. Though it does not refer to a “stationary” coil, it requires “means to
secure said coil in a predetermined fixed position” and repeats the requirement
of a “control circuit means” to control amplitude and frequency. The broad
monopoly asserted in claim 1 reads:
1. An electro-magnetic low-frequency therapeutic system comprising a
magnetization coil for creating an electro-magnetic field, means to secure said
coil in a predetermined fixed position, generator means for feeding said coil
with predetermined treatment signals to obtain a desired magnetic field
characteristic, control circuit means for selecting desired characteristics of
said treatment signals, said control circuit means having (i) circuit control
means for controlling the peak intensity of said desired magnetic field, (ii)
frequency control means to select the frequency of said treatment signals to
obtain a selected type of a plurality of treatment signals, (iii) adjustment
means to preset the duration time of said treatment signals and said
electro-magnetic field, said desired magnetic field characteristics being
predetermined from a magnetic field pattern chart representative of the
parameters of the field of said magnetization coil in the surrounding
environment of said coil whereby to obtain a desired range of intensity of said
field and a desired orientation thereof relative to a position of said coil.
19
This appeal raises questions of both validity and infringement. The
task of claims construction is antecedent to both inquiries.
2. Claims
Construction
20
Based on the expert evidence given at trial as to the meaning of the terms
used, and the understanding that these terms would convey at the date of the
patent to an ordinary worker skilled in the art of electro-magnetotherapy
devices and possessing the common knowledge of people engaged in that field, it
appears that while some of the elements of the '156 and '361 patents are
essential if the devices are to work as contemplated and claimed by the
inventor, others are non-essential. The non-essential elements may be
substituted or omitted without having a material effect on either the structure
or the operation of the invention described in the claims.
(a) The Essential Elements
21
The essential elements common to the claims of both the '156 and '361
patents include at least the following:
1. a control to regulate the peak amplitude and frequency of
interruption of the current which “energizes” the coil;
2. such control to be provided by “circuit means”.
22
For purposes of this appeal, it is unnecessary to detail the other
features of the invention. The argument is that a device which does not
include these essential elements is clearly “outside the fence” of the claimed
monopoly.
(b) The Non-essential Elements
23
The '156 patent includes a number of additional claims dependent on
claim 1. Thus, for example, claims 4 and 5 claim a “repeatedly discharged
capacitor” that fires an electric current through a damping resistor into a
magnetization coil and can be wired to break the current up into pulses
(“pulsatile” wave forms) to produce magnetic fields. The appellant argues that
any such apparatus would infringe its patent. However, the evidence is that
much of this equipment is commonly used in university science laboratories and
in other settings involving the production of magnetic fields using electric
currents through coiled wires. They are included in the patent only because of
their use in conjunction with “essential” elements of the invention described
in claim 1. In the case of some of these specific components, anyone skilled
in the art reading the patent at the date of its publication would immediately
have appreciated that there existed different commonly known substitutes or
mechanical equivalents that would do the job just as well. The claims of the
'361 patent also contemplate a number of interchangeable components that do not
constitute part of the essential invention. Thus, claims 5, 14 and 20 of the
'361 patent refer to the use of switches in conjunction with the device
described in claim 1. These components themselves were not patented on their
own – indeed, they could not be patented since they represent equipment
commonly known and used by persons skilled in electrical engineering. They
came to be included in the claim as an element of an ingenious combination.
Substitution of one type of switch for another in this case would not strike at
the essentials of the invention.
3. Validity
of the Patents in Issue
24
The trial judge declared the patents to be invalid because he agreed
with the respondents that the inventions described in the '156 and '361 patents
were fully anticipated by the publication of the article in 1975 by Solov'eva.
The “invention” was thus considered to have been described “in a . . .
publication printed in Canada or any other country more than two years” before
the filing of the patent application and thus unpatentable by virtue of
s. 28(2) of the Act.
25
Anticipation by publication is a difficult defence to establish because
courts recognize that it is all too easy after an invention has been disclosed
to find its antecedents in bits and pieces of earlier learning. It takes
little ingenuity to assemble a dossier of prior art with the benefit of
20-20 hindsight. In this case, the respondents contended that all of the
essential elements of the appellant's alleged inventions were disclosed in a
single publication, the Solov'eva article, which predated the patent
application by almost 4 years. If this is correct, the patent would be
invalid.
26
The Solov'eva article was drawn to the respondents' attention by the
appellant who cited it as prior art in the specification of the '361 patent
itself. The legal question is whether the Solov'eva article contains sufficient
information to enable a person of ordinary skill and knowledge in the field to
understand, without access to the two patents, “the nature of the invention and
carry it into practical use without the aid of inventive genius but purely by
mechanical skill” (H. G. Fox, The Canadian Law and Practice Relating to
Letters Patent for Inventions (4th ed. 1969), at pp. 126-27). In
other words, was the information given by Solov'eva “for [the] purpose of
practical utility, equal to that given in the patents in suit”? (Consolboard
Inc. v. MacMillan Bloedel (Sask.) Ltd., [1981] 1 S.C.R. 504, per
Dickson J. at p. 534), or as was memorably put in General Tire & Rubber
Co. v. Firestone Tyre & Rubber Co., [1972] R.P.C. 457 (Eng. C.A.), at
p. 486:
A signpost, however clear, upon the road to the patentee's invention
will not suffice. The prior inventor must be clearly shown to have planted his
flag at the precise destination before the patentee.
The test for
anticipation is difficult to meet:
One must, in effect, be able to look at a prior, single publication and
find in it all the information which, for practical purposes, is needed to
produce the claimed invention without the exercise of any inventive skill. The
prior publication must contain so clear a direction that a skilled person
reading and following it would in every case and without possibility of error
be led to the claimed invention.
(Beloit Canada Ltd. v. Valmet OY (1986), 8 C.P.R. (3d) 289
(F.C.A.), per Hugessen J.A., at p. 297)
27
It is clear, with respect, that the Solov'eva article does not address,
let alone solve, the technical problems dealt with in the patents in suit. It
is nothing more than a four-page overview of the history of
electro-magnetotherapy. It describes some of the various systems available in
1975 in Europe and Japan. The appellant, it must be appreciated, does not
claim to have invented electro-magnetotherapy. It obtained a patent for a
particular means. Although the various components were earlier known to
persons skilled in the art, the inventor brought the elements together to
achieve what the Commissioner of Patents considered a new, useful and ingenious
result. The claimed invention effected an ingenious combination rather than a
mere aggregation of previously known components (The King v. Uhlemann
Optical Co., [1952] 1 S.C.R. 143, per Rinfret C.J., at p. 150; Domtar
Ltd. v. MacMillan Bloedel Packaging Ltd. (1977), 33 C.P.R. (2d) 182
(F.C.T.D.), at pp. 189-91). The ingenious combination was neither taught nor
anticipated in the Solov'eva publication. None of the other arguments against
validity are convincing. The patentee lived up to its side of the bargain by
disclosing an invention. The patents are valid.
4. Infringement
Issues
28
The appeal in this Court was essentially directed to the infringement
issues. It has been established, at least since Grip Printing and
Publishing Co. of Toronto v. Butterfield (1885), 11 S.C.R. 291, that a
patent owner has a remedy against an alleged infringer who does not take the
letter of the invention but nevertheless appropriates its substance (or “pith
and marrow”). This extended protection of the patentee is recognized in
Anglo-Canadian law, and also finds expression in modified form in the United
States under the doctrine of equivalents, which is said to be available against
the producer of a device that performs substantially the same function in
substantially the same way to obtain substantially the same result: Graver
Tank & Mfg. Co. v. Linde Air Products Co., 339 U.S. 605 (1950), at p.
608.
29
It is obviously an important public policy to control the scope of
“substantive infringement”. A purely literal application of the text of the
claims would allow a person skilled in the art to make minor and
inconsequential variations in the device and thereby to appropriate the
substance of the invention with a copycat device while staying just outside the
monopoly. A broader interpretation, on the other hand, risks conferring on the
patentee the benefit of inventions that he had not in fact made but which could
be deemed with hindsight to be “equivalent” to what in fact was invented. This
would be unfair to the public and unfair to competitors. It is important that
the patent system be fair as well as predictable in its operation.
30
The argument for the respondents is that even if the patents are valid,
the appellant is not sticking to the bargain it made. It is pushing the
envelope of the doctrine of “substantive infringement” beyond anything
disclosed or claimed in its patent specifications. The inventor brought
together known components to achieve a useful and ingenious result, but now
attacks the respondents' device which brings together different
components to achieve a comparable result.
31
The appeal thus raises the fundamental issue of how best to resolve the
tension between “literal infringement” and “substantive infringement” to
achieve a fair and predictable result. There has been considerable discussion
of this issue in Canada and elsewhere, which I will discuss briefly in support
of the following propositions:
(a) The Patent Act promotes adherence to the language of the
claims.
(b) Adherence to the language of the claims in turn promotes both
fairness and predictability.
(c) The claim language must, however, be read in an informed and
purposive way.
(d) The language of the claims thus construed defines the monopoly.
There is no recourse to such vague notions as the “spirit of the invention” to
expand it further.
(e) The claims language will, on a purposive construction, show that
some elements of the claimed invention are essential while others are
non-essential. The identification of elements as essential or non-essential is
made:
(i) on the basis of the common knowledge of the worker skilled in the
art to which the patent relates;
(ii) as of the date the patent is published;
(iii) having regard to whether or not it was obvious to the
skilled reader at the time the patent was published that a variant of a
particular element would not make a difference to the way in which the
invention works; or
(iv) according to the intent of the inventor, expressed or
inferred from the claims, that a particular element is essential irrespective
of its practical effect;
(v) without, however, resort to extrinsic evidence of the
inventor's intention.
(f) There is no infringement if an essential element is different or
omitted. There may still be infringement, however, if non-essential elements
are substituted or omitted.
32
Based on the foregoing principles, I conclude that the appellant's
arguments must be rejected. As stated, the ingenuity of the patent lies not in
the identification of a desirable result but in teaching one particular means
to achieve it. The claims cannot be stretched to allow the patentee to
monopolize anything that achieves the desirable result. It is not legitimate,
for example, to obtain a patent for a particular method that grows hair on bald
men and thereafter claim that anything that grows hair on bald men
infringes. I turn then to the first of the propositions listed above.
(a) The Patent Act Promotes Adherence
to the Language of the Claims
33
The Patent Act requires the letters patent granting a patent
monopoly to include a specification which sets out a correct and full
“disclosure” of the invention, i.e., “correctly and fully describe[s] the
invention and its operation or use as contemplated by the inventor” (s. 34(1) (a)).
The disclosure is followed by “a claim or claims stating distinctly and in
explicit terms the things or combinations that the applicant regards as new and
in which he claims an exclusive property or privilege” (s. 34(2) ). It is
the invention thus claimed to which the patentee receives the “exclusive right,
privilege and liberty” of exploitation (s. 44 ). These provisions, and similar
provisions in other jurisdictions, have given rise to two schools of thought.
One school holds that the claim embodies a technical idea and claims
construction ought to look to substance rather than form to protect the
inventive idea underlying the claim language. This is sometimes called the
“central claim drafting principle” and is associated with the German and
Japanese patent systems: T. Takenaka, “Doctrine of Equivalents after Hilton
Davis: A Comparative Law Analysis” (1996), 22 Rutgers Computer &
Tech. L. J. 479, at pp. 491, 502 and 519. The other school of thought
supporting what is sometimes called the “peripheral claiming principle”
emphasizes the language of the claims as defining not the underlying technical
idea but the legal boundary of the state-conferred monopoly. Traditionally,
for reasons of fairness and predictability, Canadian courts have preferred the
latter approach.
34
The “spirit of the invention” school in this country relies on Electrolier
Manufacturing Co. v. Dominion Manufacturers Ltd., [1934] S.C.R. 436. In
that case, which involved a method to pivot handles for coffins, Rinfret J.
spoke of “the spirit of the invention” but did so in a direct quote from the
patent itself, at p. 443:
What the appellant did – and in that his infringement
truly consists – was to take the idea which formed the real subject-matter of
the invention. It does not matter whether he also adopted the substitution of
the two holes for the bar in the pivoting means. The precise form of these
means was immaterial. In the language of the patent, they could be
changed “without departing from the spirit of the invention”. [Emphasis
added.]
Rinfret J.
went on at p. 444 to tie explicitly his finding of infringement to a “fair
interpretation of the language of the specification”.
35
The debate between the advocates of the “central claiming principle” and
advocates of the “peripheral claiming principle” can each find precedents to
support them. As long ago as Smith Incubator Co. v. Seiling, [1936]
S.C.R. 251, at p. 259, counsel pointed out that there appeared to be these two
mutually inconsistent lines of authority:
According to one of these it is proper to consider
what is “the pith and substance” or the “spirit” of the invention and to give
effect to the patent accordingly. The other is to regard the claims as
definitely determining the scope of the monopoly which the patent purports to
grant and to give or refuse them effect according to the expressions they
contain when these expressions are properly construed and their meaning
determined.
To which
Rinfret J., for the Court, responded at pp. 259-60:
In our view, the rule is that the claims must be
regarded as definitely determining the scope of the monopoly, having regard to
the due and proper construction of the expressions they contain.
36
In J. K. Smit & Sons, Inc. v. McClintock, [1940] S.C.R. 279,
Duff C.J., for the Court, reversed the Exchequer Court finding of infringement
because he could not “find in these claims the description of a monopoly which
clearly and plainly includes a prohibition” (p. 287) against the alleged
infringement. Gillette Safety Razor Co. of Canada v. Pal Blade Corp.,
[1933] S.C.R. 142, per Rinfret J. at p. 147, is to the same effect.
37
With respect to the United States, I mentioned earlier the seminal Graver
Tank case in 1950. More recently, the United States Supreme Court
revisited the doctrine of equivalents in Warner-Jenkinson Co. v. Hilton
Davis Chemical Co., 520 U.S. 17 (1997), and concluded, per Thomas
J., at pp. 28-29:
We do, however, share the concern of the dissenters
below that the doctrine of equivalents, as it has come to be applied since Graver
Tank, has taken on a life of its own, unbounded by the patent claims.
There can be no denying that the doctrine of equivalents, when applied broadly,
conflicts with the definitional and public-notice functions of the statutory
claiming requirement.
38
The U.S. approach is to disaggregate the invention as described in the
patent claims into its constituent parts, as we do, but instead of
characterizing an element as essential or non-essential, they treat all
elements as “material”, per Thomas J., at p. 29:
Each element contained in a patent claim is deemed material to defining
the scope of the patented invention, and thus the doctrine of equivalents must
be applied to individual elements of the claim, not to the invention as a
whole. It is important to ensure that the application of the doctrine, even as
to an individual element, is not allowed such broad play as to effectively
eliminate that element in its entirety.
Flexibility is
thus achieved under the U.S. doctrine of equivalents by asking whether each of
the component elements of the invention as claimed is present in the accused
device either as literally described in the claim, or by its “equivalent”.
Knowledge of interchangeability is evaluated as at the date of infringement,
not the date of the patent (ibid., at p. 37). The U.S. approach thus
uses the patent claims as a springboard to other considerations (including
prosecution history estoppel) some of which are extrinsic to the claims
themselves.
39
The English courts have also engaged in a debate about the proper reach
of a patent monopoly. In Clark v. Adie (1873), L.R. 10 Ch. 667, at p.
675, James L.J. spoke of “an essence or substance of the invention underlying
the mere accident of form; and that invention, like every other invention, may
be pirated by a theft in a disguised or mutilated form”. On the other hand, in
Electric & Musical Industries Ld. v. Lissen Ld. (1939), 56 R.P.C. 23
(H.L.), Lord Russell stated at p. 39:
A patentee who describes an invention in the body of a specification
obtains no monopoly unless it is claimed in the claims. . . . [T]here is no
such thing as infringement of the equity of a patent. . . .
The primacy of
the language of the claims was emphatically affirmed in the celebrated case of Catnic
Components Ltd. v. Hill & Smith Ltd., [1982] R.P.C. 183 (H.L.). The Catnic
approach has been accepted in New Zealand: Interpress Associates Ltd. v.
Pacific Coilcoaters Ltd. (1994), 29 I.P.R. 635 (H.C.), and Smale v.
North Sails Ltd., [1991] 3 N.Z.L.R. 19 (H.C.); and in Australia in Populin
v. H.B. Nominees Pty. Ltd. (1982), 59 F.L.R. 37 (Fed. Ct. (Gen. Div.), at
p. 43, and Rhone-Poulenc Agrochimie SA v. UIM Chemical Services Pty. Ltd.
(1986), 68 A.L.R. 77 (Fed. Ct. (Gen. Div.)), at pp. 92-93; in South Africa in Multotec
Manufacturing (Pty.) Ltd. v. Screenex Wire Weaving Manufacturers (Pty.)
Ltd., 1983 (1) SA 709 (App. Div.), and Sappi Fine Papers (Pty.) Ltd. v.
ICI Canada Inc. (Formerly CIL Inc.), 1992 (3) SA 306 (App. Div.); and in
Hong Kong in Improver Corp. v. Raymond Industrial Ltd., [1991] F.S.R.
233 (C.A.). The Catnic decision has its critics, of course,
particularly among those who feel its subsequent application under the European
Patent Convention denies the patentee the higher level of protection for
patentees afforded in continental Europe. For some critics, the claims should
more properly be treated not as a “fence” but as a “guidepost”: J. D. C.
Turner, “Purposive Construction: Seven Reasons Why Catnic is Wrong” (1999), 21
E.I.P.R. 531; M. Sajewycz, “Patent Claim Interpretation as It Should
Be: Promoting the Objects of the Patent Act ” (1996-97), 13 C.I.P.R.
173; R. E. Annand, “Infringement of Patents -- Is “Catnic” the Correct
Approach for Determining the Scope of a Patent Monopoly Under the Patents Act
1977?” (1992), 21 Anglo-Am. L. Rev. 39.
40
The judgment of Lord Diplock was considered and applied by our Federal
Court of Appeal in Eli Lilly & Co. v. O'Hara Manufacturing Ltd. (1989),
26 C.P.R. (3d) 1, and its progeny. The primacy of the claims language was
already rooted deeply in our jurisprudence and should, I think, be affirmed
again on this appeal.
(b) Adherence to the Language of the Claims
in Turn Promotes both Fairness and Predictability
41
The scope of patent protection must not only be fair, it must be
reasonably predictable. A patent is, after all, a public instrument issued
under statutory authority which may result in severe financial consequences for
its infringement. The scope of its prohibition should be made clear so that
members of the public may know where they can go with impunity. As was said in
another public law connection by Gonthier J. in R. v. Nova Scotia
Pharmaceutical Society, [1992] 2 S.C.R. 606, at p. 639, precision in
public enactments is required to “sufficiently delineate an area of risk”.
42
The patent system is designed to advance research and development and to
encourage broader economic activity. Achievement of these objectives is
undermined however if competitors fear to tread in the vicinity of the patent
because its scope lacks a reasonable measure of precision and certainty. A
patent of uncertain scope becomes “a public nuisance” (R.C.A. Photophone,
Ld. v. Gaumont-British Picture Corp. (1936), 53 R.P.C. 167 (Eng. C.A.), at
p. 195). Potential competitors are deterred from working in areas that are not
in fact covered by the patent even though costly and protracted litigation
(which in the case of patent disputes can be very costly and protracted indeed)
might confirm that what the competitors propose to do is entirely lawful.
Potential investment is lost or otherwise directed. Competition is “chilled”.
The patent owner is getting more of a monopoly than the public bargained for.
There is a high economic cost attached to uncertainty and it is the proper
policy of patent law to keep it to a minimum.
43
The patent owner, competitors, potential infringers and the public
generally are thus entitled to clear and definite rules as to the extent of the
monopoly conferred. This in turn requires that the subjective or discretionary
element of claims interpretation (e.g., the elusive quest for “the spirit of
the invention”) be kept to the minimum, consistent with giving “the inventor
protection for that which he has actually in good faith invented” (Western
Electric Co. v. Baldwin International Radio of Canada, [1934] S.C.R. 570,
at p. 574). Predictability is achieved by tying the patentee to its
claims; fairness is achieved by interpreting those claims in an informed and
purposive way.
(c) The Claims Must Be Construed in an Informed and Purposive Way
44
The courts have traditionally protected a patentee from the effects of
excessive literalism. The patent is not addressed to an ordinary member of the
public, but to a worker skilled in the art described by Dr. Fox as
a hypothetical person possessing the ordinary skill and knowledge of
the particular art to which the invention relates, and a mind willing to
understand a specification that is addressed to him. This hypothetical person
has sometimes been equated with the “reasonable man” used as a standard in
negligence cases. He is assumed to be a man who is going to try to achieve
success and not one who is looking for difficulties or seeking failure.
(Fox, supra, at p. 184)
It is the
“common knowledge” shared by competent “ordinary workers” that is brought to
bear on the interpretation: Fox, supra, at p. 204; Terrell on the
Law of Patents (15th ed. 2000), at p. 125; I. Goldsmith, Patents of
Invention (1981), at p. 116. The present appeal does not raise great
subtleties of interpretation. The experts called by the parties here more or
less agreed on the significance of what is stated in the claims. The
electro-magnetotherapy is to be controlled by “circuit means”. The present
appeal turns on the scope of the legal protection that arises out of that fact.
(d) The Language of
the Claims Thus Construed Defines the Monopoly. There Is no Recourse to such
Vague Notions as “Spirit of the Invention” to Expand it Further
45
There appears to be a continuing controversy in some quarters as to
whether there are two approaches to infringement (literal and substantive) or
only one approach, namely infringement of the claims as written but
“purposively” construed.
46
In the two-step approach, the court construes the claims and determines
whether the device accused of infringement has literally taken the invention.
If not, the court proceeds to the second step of asking itself whether “in
substance” the invention was wrongfully appropriated. On occasion, treatment
of the second step in specific cases has attracted criticism as being
subjective and unduly discretionary. Once the inquiry is no longer anchored in
the language of the claims, the court may be heading into unknown waters
without a chart. The one-step approach has to build flexibility and common
sense into the initial claims construction because there is no second step.
47
The “single cause of action” approach was advocated by Lord Diplock in Catnic,
supra, at p. 242:
My Lords, in their closely reasoned written cases
in this House and in the oral argument, both parties to this appeal have tended
to treat “textual infringement” and infringement of the “pith and marrow” of an
invention as if they were separate causes of action, the existence of the
former to be determined as a matter of construction only and of the latter upon
some broader principle of colourable evasion. There is, in my view, no such
dichotomy; there is but a single cause of action and to treat it otherwise,
particularly in cases like that which is the subject of the instant appeal, is
liable to lead to confusion.
48
The Catnic approach was adopted in O'Hara, and has been
carried forward by the Federal Court of Appeal in cases such as Mobil Oil
Corp. v. Hercules Canada Inc. (1995), 63 C.P.R. (3d) 473, per
Marceau J.A., at p. 489:
It is my opinion that one should not endeavour to create a distinction
between a substantial and a literal infringement in a case such as this; one
should construe the claims so as to determine what exactly lies within the
scope of the inventor's rights. Once this has been determined, then one can
consider the defendant's product to decide if it falls within the scope of the
claim.
However, other
decisions of different panels of our Federal Court of Appeal have occasionally
sought to breathe life into the earlier dichotomy: see Computalog Ltd. v.
Comtech Logging Ltd. (1992), 44 C.P.R. (3d) 77, at pp. 80-81, and Feherguard
Products Ltd. v. Rocky's of B.C. Leisure Ltd. (1995), 60 C.P.R. (3d) 512.
B. H. Sotiriadis in “Purposive Construction in Canadian Patent
Infringement Cases Since O'Hara” (1996), 11 I.P.J. 111, notes at
p. 116:
In fact, notwithstanding O'Hara, the Court of Appeal [in Imperial
Oil v. Lubrizol (1992), 45 C.P.R. (3d) 449] went so far as to state that
the notion of the “pith and marrow” of an invention in patent cases was a
principle that remains “alive and well and applicable in the case before the
court.”
49
Similarly, in C. V. E. Hitchman and D. H. MacOdrum, “Don't Fence Me In:
Infringement in Substance in Patent Actions” (1990-91), 7 C.I.P.R. 167,
the authors, at p. 201, cite Cutter (Canada) Ltd. v. Baxter Travenol
Laboratories of Canada Ltd. (1983), 68 C.P.R. (2d) 179 (F.C.A.), and Johnson
Controls, Inc. v. Varta Batteries Ltd. (1984), 80 C.P.R. (2d) 1 (F.C.A.),
as evidence of continuing post-Catnic adherence to the two-step approach
and conclude, “[i]t is too early to say whether that Court following O'Hara
will focus solely on the Catnic test”.
50
I do not suggest that the two-stage approach necessarily ends at a
different destination than the one-stage approach, or that the two-stage
approach has resulted in abuse. I think we should now recognize, however, that
the greater the level of discretion left to courts to peer below the language
of the claims in a search for “the spirit of the invention”, the less the
claims can perform their public notice function, and the greater the resulting
level of unwelcome uncertainty and unpredictability. “Purposive construction”
does away with the first step of purely literal interpretation but disciplines
the scope of “substantive” claims construction in the interest of fairness to
both the patentee and the public. In my view its endorsement by the Federal
Court of Appeal in O'Hara was correct.
(e) The Claims Language Will, on a Purposive
Construction, Show that Some Elements of the Claimed Invention Are Essential
While Others Are Non-essential. This Allocation Will Be Made in the Following
Manner:
(i) On the Basis of the Common Knowledge of
the Worker Skilled in the Art to which the Patent Relates
51
This point is addressed more particularly in Whirlpool Corp. v. Camco
Inc., [2000] 2 S.C.R. 1067, 2000 SCC 67 and Whirlpool Corp. v. Maytag
Corp., [2000] 2 S.C.R. 1116, 2000 SCC 68, released concurrently. The
involvement in claims construction of the skilled addressee holds out to the
patentee the comfort that the claims will be read in light of the knowledge
provided to the court by expert evidence on the technical meaning of the terms
and concepts used in the claims. The words chosen by the inventor will be read
in the sense the inventor is presumed to have intended, and in a way that is
sympathetic to accomplishment of the inventor's purpose expressed or implicit
in the text of the claims. However, if the inventor has misspoken or otherwise
created an unnecessary or troublesome limitation in the claims, it is a
self-inflicted wound. The public is entitled to rely on the words used provided
the words used are interpreted fairly and knowledgeably.
(ii) What Constitutes an “Essential” Element
Is to Be Interpreted in Light of the Knowledge of the Art at the Date of the
Publication of the Patent Specification
52
The substitutability of non-essential elements derives from an informed
interpretation of the language of the claims at the time they are revealed to
the target audience of persons skilled in the relevant art. Thus Dickson J.,
in Consolboard, supra, spoke at p. 523 of “what a competent workman
reading the specification at its date would have understood it to have
disclosed and claimed” (emphasis added). See also Fox, supra, at p.
204. The date of publication was identified by Lord Diplock in Catnic, supra,
and picked up by Hoffmann J. (as he then was) in Improver Corp. v. Remington
Consumer Products Ltd., [1990] F.S.R. 181 (Pat. Ct.), at p. 182:
Would this (i.e.: that the variant had no material effect) have been
obvious at the date of publication of the patent to a reader skilled in
the art? If no, the variant is outside the claim. [Emphasis added.]
53
The date of publication continues to be the critical date in England:
Terrell, supra, at p. 106, although Lord Hoffmann (as he now is) has
observed that “there is an important difference between the 1949 [Patent Act ]
and the 1977 [Patent Act ]” which requires the date of application (or
priority date) to become the critical date for certain purposes: Biogen
Inc. v. Medeva PLC, [1997] R.P.C. 1 (H.L.), at p. 54. In that case the
court was dealing with the sufficiency of disclosure, but some English judges
have taken the cue to construe claims as of the date of application as well,
e.g., Dyson Appliances Ltd. v. Hoover Ltd., [2000] E.W.J. No. 4994
(QL)(Pat. Ct.), at para. 48 (k). In Canada, Reed J. advocated a similar
position in AT & T Technologies, Inc. v. Mitel Corp. (1989), 26
C.P.R. (3d) 238 (F.C.T.D.), at p. 260, even in the absence of these statutory
changes. While there may be some advantages to the establishment of a single
critical date for multiple purposes including obviousness, sufficiency and
claims construction, my view is that Canadian law does not support the date of
application as the critical date for claims construction.
54
There remains, however, a choice between the date of issuance of the
patent and the date of its publication because under the former Act the date of
issue and the date of publication were the same. Now, as a result of the
obligations assumed by Canada under the 1970 Patent Cooperation Treaty
implemented by s. 10 of the new Act (S.C. 1993, c. 15, s. 28), the patent
specification is “laid open” 18 months after the effective date of the Canadian
patent application. In my view, the same logic that favoured the date of
issuance/publication as the critical date for claims construction under the
former Act, favours the choice of the “laid open” date under the new Act. On
that date, the invention is disclosed to the public, those interested have some
ability to oppose the grant of the patent applied for, and the applicant for
the patent is eventually allowed to claim reasonable compensation (s. 55(2)),
provided the patent is ultimately granted, from and after the “laid open”
date. The public, the patentee, its competitors and potential infringers all
have an interest and/or concern from that date forward. The notional skilled
addressee has a text available for interpretation. In summary, public
disclosure and the triggering of legal consequences on the “laid open” date, as
well as the policy considerations that underpinned the earlier case law, favour
that date over the other possibilities as the critical date for the purpose of
claims construction.
(iii) Regard Is to Be Had to Whether It Was
Obvious at the Time the Patent Was Published that Substitution of a Different
Variant Would Make a Difference to the Way in Which the Invention Works
55
It would be unfair to allow a patent monopoly to be breached with
impunity by a copycat device that simply switched bells and whistles, to escape
the literal claims of the patent. Thus the elements of the invention are
identified as either essential elements (where substitution of another element
or omission takes the device outside the monopoly), or non-essential elements
(where substitution or omission is not necessarily fatal to an allegation of
infringement). For an element to be considered non-essential and thus
substitutable, it must be shown either (i) that on a purposive construction of
the words of the claim it was clearly not intended to be essential, or
(ii)
that at the
date of publication of the patent, the skilled addressees would have
appreciated that a particular element could be substituted without affecting
the working of the invention, i.e., had the skilled worker at that time been
told of both the element specified in the claim and the variant and “asked
whether the variant would obviously work in the same way”, the answer would be
yes: Improver Corp. v. Remington, supra, at p. 192. In
this context, I think “work in the same way” should be taken for our purposes
as meaning that the variant (or component) would perform substantially the same
function in substantially the same way to obtain substantially the same
result. In Improver Corp. v. Remington, Hoffmann J. attempted to reduce
the essence of the Catnic analysis to a series of concise questions, at
p. 182:
(i) Does the variant have a material effect upon
the way the invention works? If yes, the variant is outside the claim. If no:
–
(ii) Would this (i.e.: that the variant had no
material effect) have been obvious at the date of publication of the patent to
a reader skilled in the art? If no, the variant is outside the claim. If yes:
–
(iii) Would the reader skilled in the art nevertheless
have understood from the language of the claim that the patentee intended that
strict compliance with the primary meaning was an essential requirement of the
invention? If yes, the variant is outside the claim.
56
The three questions are not exhaustive but they encapsulate the heart of
Lord Diplock's analysis, and have been endorsed in subsequent English cases.
57
In AT & T Technologies, supra, at p. 257, Reed J.
derived a series of interpretive principles from Catnic, supra, O'Hara,
supra, and other cases. Her third principle is as follows:
(3) if a variant of an aspect of a claim has no material effect on the
way the invention works there is a presumption that the patent is
infringed and that the patentee intended that that variant falls within
the scope of the claim. . . . [Emphasis added.]
The
desirability of such a presumption is supported by some commentators (see,
e.g., J.-C. Boudreau, “AT&T Technologies: A Contribution to the Purposive
Construction Approach for Patent Infringement Analysis in Canada” (1998-99), 15
C.I.P.R. 323). If this proposition is taken to mean that a presumption
of non-essentiality will arise if it is established in light of the knowledge
of substitutability existing at the date of the infringement (AT
& T Technologies, supra, at p. 262) that a variant would have no
material effect on the way the invention works then, with respect, I disagree
with it. The effect would be that the ambit of the monopoly would grow over
the life of the patent as new substitutes are developed and absorbed into the
common knowledge of the skilled worker. The inventor cannot be thought to have
the necessary “intent” in relation to after-created knowledge except in the
irrelevant sense of intending to reap the benefit of the maximum coverage
available. In my view, Catnic, supra, and O'Hara, supra,
were correct to put the onus on the patentee to establish known and obvious
substitutability at the date of publication of the patent. If the patentee
fails to discharge that onus, the descriptive word or expression in the claim
is to be considered essential unless the context of the claims language
otherwise dictates.
(iv) According to the Intent of the Inventor
Expressed or Inferred from the Claims of the Patent
58
The inventor is addressing others in the same line of work. Words have
layers of significance and secondary meanings. A reference to “turf” means
something different to racehorse owners than it does to warring business
executives. The word “bench” means a physical object to weightlifters but has
numerous secondary meanings for members of the legal profession. The courts
recognize the pitfalls of language and will do what they can to give the
inventor “protection for that which he has actually in good faith invented” (Western
Electric, supra, at p. 574), but there are limits.
59
In O’Hara, supra, the Federal Court of Appeal held
that a patent for a pill coating machine that specified a flexible
exhaust could not be interpreted to cover a machine that fulfilled the same
function and contained all of the other essential elements but which utilized a
fixed exhaust. Pratte J.A., for the court, considered it important that
the patentee had specified “exhaust inlet flexibly biased”, and must be taken
to have attached significance to the words chosen (at p. 7):
. . . unless it be obvious that the inventor knew that a failure to
comply with that requirement would have no material effect upon the way the
invention worked.
Pratte J.A.
also stated:
A court must interpret the claims; it cannot redraft them. When an
inventor has clearly stated in the claims that he considered a requirement as
essential to his invention, a court cannot decide otherwise for the sole reason
that he was mistaken.
To the same
effect see J. K. Smit & Sons, supra, per
Duff C.J., at p. 285.
60
The facts of O'Hara have an echo in the facts of this case.
Claim 1 of the '156 patent stipulates the “said magnetization coil being
stationary” during treatment. Whether the magnetization coil is stationary may
or may not affect the way the device works, but the inventor has explicitly so
stipulated.
(v) Based on the
Patent Specification Itself Without Resort to Extrinsic Evidence
61
In O'Hara, supra, Pratte J.A. commented at p. 7 that in
claims interpretation the Court “is merely trying to find out what was the
intention of the inventor”, and this comment has given rise to the contention
that some forms of extrinsic evidence should be admissible in claims
construction to establish the inventor's intention.
62
The intervener, Procter & Gamble Inc. urges the Court to allow proof
of the intent through evidence of representations to the Patent Office in the
course of patent prosecution, i.e., the negotiations over the wording of the
claims leading up to issuance of the patent. In her reasons, Rousseau-Houle
J.A. made limited reference to the prosecution history in the present case as
follows (at pp. 461-62):
[translation]During
his study of the patent applications, the Commissioner analyzed various systems
described in American and German patents which also were developed to treat the
human body through the creation of magnetic fields. He examined the article by
Solov'eva which the appellant quoted and specifically commented in patent
application 361. . . . He requested additional details with respect to certain
of the claims described in the patents and ordered amendments to the
descriptions of certain functions and the deletion of any reference to methods
of treatment because methods are not patentable. [Emphasis added.]
63
In the United States, representations to the Patent Office were
historically noted on the file cover or “wrapper”, and the doctrine is thus
known in that country as “file wrapper estoppel” or “prosecution history
estoppel”. In its recent decision in Warner-Jenkinson Co., supra,
the United States Supreme Court affirmed that a patent owner is precluded from
claiming the benefit of the doctrine of equivalents to recapture ground
conceded by limiting argument or amendment during negotiations with the Patent
Office. The availability of file wrapper estoppel was affirmed, but it was
narrowed in the interest of placing “reasonable limits on the doctrine of
equivalents”, per Thomas J., at p. 34. While prosecution history
estoppel is still tied to amendments made to avoid the prior art, or otherwise
to address a specific concern – such as obviousness -- that arguably would have
rendered the claimed subject matter unpatentable, the court placed the burden
on the patentee to establish the reason for an amendment required during patent
prosecution. Where no innocent explanation is established, the court will now
presume that the Patent Office had a substantial reason related to patentability
for including the limiting element added by amendment. In those circumstances,
prosecution history estoppel bars the application of the doctrine of
equivalents as to that element.
64
The use of file wrapper estoppel in Canada was emphatically rejected by
Thorson P. in Lovell Manufacturing Co. v. Beatty Bros. Ltd. (1962), 23
Fox Pat. C. 112 (Ex. Ct.), and our Federal Court has in general confirmed over
the years the exclusion of file wrapper materials tendered for the purpose of
construing the claims: see, e.g., P.L.G. Research Ltd. v. Jannock Steel
Fabricating Co. (1991), 35 C.P.R. (3d) 346 (F.C.T.D.), at p. 349. No
distinction is drawn in this regard between cases involving allegations of
literal infringement and those involving substantive infringement.
65
Counsel for Procter & Gamble Inc. argues that prosecutions history
ought to be admissible in some circumstances in the interest of obtaining
consistent claims interpretation here and in the United States, where many
Canadian patents have their origin. There is some nourishment for this
proposition in commentary by other experienced practitioners (e.g., D. W.
Scott, “The Record of Proceedings in the Patent Office in Canada & Foreign
Countries as Evidence in Infringement & Validity Contests” (1985-86), 2 C.I.P.R.
160). References to the intention of the inventor in Catnic, supra,
and O'Hara, supra, are said to leave the door ajar to the
possibility of reconsideration.
66
In my view, those references to the inventor's intention refer to an
objective manifestation of that intent in the patent claims, as interpreted by
the person skilled in the art, and do not contemplate extrinsic evidence such
as statements or admissions made in the course of patent prosecution. To allow
such extrinsic evidence for the purpose of defining the monopoly would
undermine the public notice function of the claims, and increase uncertainty as
well as fuelling the already overheated engines of patent litigation. The
current emphasis on purposive construction, which keeps the focus on the
language of the claims, seems also to be inconsistent with opening the
pandora's box of file wrapper estoppel. If significant representations are
made to the Patent Office touching the scope of the claims, the Patent Office
should insist where necessary on an amendment to the claims to reflect the
representation.
67
This is not to suggest that prosecution history can never be relevant
for a purpose other than defining the scope of the grant of the monopoly: Foseco
Trading A.G. v. Canadian Ferro Hot Metal Specialties, Ltd. (1991), 36
C.P.R. (3d) 35 (F.C.T.D.), at p. 47. That point does not arise in this
case for decision and lies outside the scope of these reasons.
(f) Based on the Foregoing Principles, the
Respondents' Device Is Outside the Claimed Monopoly and the Appeal Must Be
Dismissed
68
While the foregoing principles will have to be adapted to the exigencies
of different types of patents, it may be helpful to summarize how they apply in
this case.
(1) At the claims construction stage, the wording of the claims was
analysed to isolate the descriptive words and phrases which identify the
elements of the invention. There is no need here to make heavy weather in the
details. The claims specify the presence of “circuit means” to control the
electro-magnetotherapy. There is nothing in the context of the claims to
suggest that the inventor considered circuit means to be non-essential. On the
contrary, it is the core of the invention. Equally, there was no evidence that
at the date of publication of the patent the ordinary skilled worker would have
appreciated that there were variants that could perform substantially the same
function in substantially the same way to achieve substantially the same
result as the circuit means specified in the patent.
(2) Control of the magnetotherapy by circuit means was therefore an
essential element of the invention.
(3) At the infringement analysis stage, the accused Électro-Santé
device is now to be examined and its constituent elements similarly identified.
(4) If the accused device takes all of the essential elements of the
invention, there is infringement.
69
The appellant complains, with some justice in my view, that having
stated its legal test of infringement, the Quebec Court of Appeal then erred in
making a comparison between the device of the appellant and the device of the
respondents, and coming to the conclusion (which the appellant did not dispute)
that the devices were different.
70
The appellant contends that the proper comparison is between the claims
set out in its patents and the devices marketed by the respondents. I agree,
but I believe that on reading the reasons of the Quebec Court of Appeal in
their entirety, the court did make the proper comparison, even though that
court went on to make a superfluous comparison between the two devices
themselves.
71
The appellant points out that the Électro-Santé device features many of
the characteristics described in claim 1 of the '156 patent. It is an
“electro-magnetic low frequency therapeutic system”. The magnetic field
intensity is adjustable by the user. There are means for controlling the
magnetic field's peak amplitude and frequency. As Wills J. said in Incandescent
Gas Light Co. v. De Mare Incandescent Gas Light System, Ld. (1896), 13
R.P.C. 301 (Q.B.D.), at p. 330:
It is seldom that the infringer does the thing, the whole thing, and
nothing but the thing claimed in the Specification.
72
The appellant however failed to establish that a skilled reader would
have understood in 1981 and 1983, when these patents were published, that (i)
the inventions as contemplated were intended to include departures (or
variants) from the specified circuit technology, (ii) that it would have been
obvious to such a skilled reader that substituting variants for the specified
“circuit means” would perform substantially the same function in substantially
the same way to produce substantially the same result, and (iii) that when the
inventor specified “circuit means” he didn't really mean the description to be
taken literally. Had the appellant been able to establish these points, its
patents would probably have been declared invalid for covetous claiming.
73
The claims clearly require “circuit means”. As mentioned, a
skilled reader in 1981 or 1983 would associate that descriptive phrase with
specific technology and consider the use of such technology essential to the
claimed invention. The fact that the Électro-Santé device uses a
microcontroller to perform a similar or even the same function does not bring
it within the claim. It performs the function in a very different way.
Moreover, there is no reason to think the inventor didn't mean what he said, or
considered the use of “circuit means” a non-essential element of the claims, or
intended to claim more broadly than “circuit means” and thereby put at risk for
“covetous claiming” the validity of the patents. As the Court of Appeal
observed, the means of control of amplitude and frequency is precisely the
difference that validated the patents over the prior art embodied in such
predecessor magnetotherapy machines as the Magnétopace, Myodynamic and Elec
devices.
74
In sum, the respondents' device differs both structurally and
operationally from the device contemplated in the claims. Substitution of a
microcontroller for the “circuit means” substitutes a totally different
technology for the core of the '156 and '361 patents and of itself is clearly
fatal to the appellant's allegation of infringement.
75
The appellant having failed to establish that the respondents'
Électro-Santé system included all of the essential elements of the monopoly set
out in its patent claims, purposively construed, the action was rightly dismissed.
V. Disposition
76
The appeal is dismissed without costs.
Appeal dismissed.
Solicitors for the appellant: Joli-Cœur, Lacasse,
Lemieux, Simard, St-Pierre, Sillery, Québec.
Solicitors for the intervener: Dimock Stratton Clarizio,
Toronto.